Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review

[31] Nicholson AG(2011)An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 602-839

[32] Richeldi L(1998)A two-compartment model of pulmonary nitric oxide exchange dynamics J Appl Physiol (Bethesda, Md: 1985) 85 653-669

[33] Selman M(2004)Modeling pulmonary nitric oxide exchange J Appl Physiol (Bethesda, Md: 1985) 96 831-231

[34] Dudden RF(2002)Dilution of respiratory solutes in exhaled condensates Am J Respir Crit Care Med 165 663-188

[35] Griss BS(2015)Breathomics in Lung Disease Chest 147 224-976

[36] Protzko SL(2016)Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis Allergy 71 175-9

[37] Schunemann HJ(2016)Breathomics in the setting of asthma and chronic obstructive pulmonary disease J Allergy Clin Immunol 138 970-956

[38] Wells AU(2017)Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis Anal Chim Acta 996 1-304

[39] Costabel U(2015)Exhaled breath analysis by electronic nose in respiratory diseases Expert Rev Mol Diagn 15 933-536

[40] Poletti V(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 277-930

[31] Nicholson AG(2011)An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 602-839

[32] Richeldi L(1998)A two-compartment model of pulmonary nitric oxide exchange dynamics J Appl Physiol (Bethesda, Md: 1985) 85 653-669

[33] Selman M(2004)Modeling pulmonary nitric oxide exchange J Appl Physiol (Bethesda, Md: 1985) 96 831-231

[34] Dudden RF(2002)Dilution of respiratory solutes in exhaled condensates Am J Respir Crit Care Med 165 663-188

[35] Griss BS(2015)Breathomics in Lung Disease Chest 147 224-976

[36] Protzko SL(2016)Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis Allergy 71 175-9

[37] Schunemann HJ(2016)Breathomics in the setting of asthma and chronic obstructive pulmonary disease J Allergy Clin Immunol 138 970-956

[38] Wells AU(2017)Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis Anal Chim Acta 996 1-304

[39] Costabel U(2015)Exhaled breath analysis by electronic nose in respiratory diseases Expert Rev Mol Diagn 15 933-536

[40] Poletti V(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 277-930